个性化他类药物治疗计划使用反事实方法,多目标优化利益和风险
Yue Liang1,2, Pui Ying Yew1,2, Matt Loth1,3,2
1Institute for Health Informatics, University of Minnesota, Minneapolis, MN, 55455, USA.
Informatics in medicine unlocked
|November 21, 2023
概括
这项研究增强了个性化他类药物治疗计划 (PSTP),以最大限度地降低患者的风险和最大限度地提高患者的益处. 改进的PSTP框架减少了与他类药物相关的症状和治疗中止,改善了心血管健康结果.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 生物统计学 生物统计学
背景情况:
- 类药物有效降低心血管疾病 (ASCVD) 风险,但可能导致不良反应,导致治疗中止和死亡率增加.
- 现有的个性化他类药物治疗计划 (PSTP) 框架存在局限性,包括缺乏反事实预测,对多目标优化处理不充分,以及回顾性评估.
- 解决这些局限性对于改善患者的坚持和心血管结果至关重要.
研究的目的:
- 为了提高PSTP框架对他类药物处方的稳定性和可用性.
- 开发一种主动策略,最大限度地减少低密度脂蛋白胆固醇 (LDL-C),同时最大限度地减少他类药物相关症状 (SAS) 和治疗中止.
- 将反事实预测,多目标优化和强大的评估方法纳入PSTP.
主要方法:
- 应用重叠权重反事实生存风险预测 (CP) 来解释混偏差.
- 利用多重目标优化 (MOO) 来平衡竞争的处方目标,例如利益与风险.
- 采用临床试验模拟 (CTS) 与各种手臂 (随机,临床指南,PSTP,实用) 进行全面的框架评估.
主要成果:
- 修订后的PSTP在所有时间点的SAS风险降低方面表现出显著的改进,与CTS的其他部门相比.
- 在一年内,PSTP在确定最佳他类药物选择方面表现出更大的灵活性.
- 临床试验模拟证实了强大的反事实风险预测和个性化的利益风险平衡的可行性.
结论:
- 增强的PSTP框架为个性化他类药物处方提供了一种强大而可靠的方法.
- 该研究成功地证明了PSTP与帕雷托优化的能力,以实现他类药物的益处和风险之间的最佳平衡.
- 改进的PSTP框架为缓解他类药物相关风险和改善长期心血管健康提供了一个有希望的解决方案.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
672
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
672
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Structure-Activity Relationships and Drug Design
733
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
733
Strategies for Assessing and Addressing Confounding
103
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
103


